Mary Kay Fenton - 20 Feb 2026 Form 4 Insider Report for Cullinan Therapeutics, Inc. (CGEM)

Role
Chief Financial Officer
Signature
/s/ Jacquelyn Sumer, Attorney-in-Fact
Issuer symbol
CGEM
Transactions as of
20 Feb 2026
Net transactions value
-$59,901
Form type
4
Filing time
23 Feb 2026, 17:00:02 UTC
Previous filing
19 Feb 2026
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Fenton Mary Kay Chief Financial Officer C/O CULLINAN THERAPEUTICS, INC., ONE MAIN STREET, SUITE 1350, CAMBRIDGE /s/ Jacquelyn Sumer, Attorney-in-Fact 23 Feb 2026 0001378589

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CGEM Common Stock Sale $59,901 -4,398 -3.4% $13.62 126,380 20 Feb 2026 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of shares to cover personal income tax obligations upon vesting of restricted stock units.